Dr Richard Press News Banner Thumbnail

Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

Published: 9 September 2024